Role of phospholamban in No/EDRF-induced relaxation in rat aorta
- 31 December 1992
- journal article
- Published by Elsevier in Life Sciences
- Vol. 51 (15), 1205-1210
- https://doi.org/10.1016/0024-3205(92)90357-u
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxideNature, 1990
- Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.Circulation Research, 1989
- Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cellsBiochemical and Biophysical Research Communications, 1988
- Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.Circulation Research, 1987
- 8‐Bromoguanosine 3′:5′‐cyclic monophosphate decreases intracellular free calcium concentrations in cultured vascular smooth muscle cells from rat aortaFEBS Letters, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Atriopeptin II decreases cytosolic free Ca in cultured vascular smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 1986
- Myosin phosphorylation and cyclic adenosine 3',5'-monophosphate in relaxation of arterial smooth muscle by vasodilators.Circulation Research, 1984
- Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylationNature, 1983
- Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.Circulation Research, 1983